Show simple item record

dc.contributor.advisorHutt, Peter Bartonen_US
dc.contributor.authorGelfond, Rebecca J.en_US
dc.date.accessioned2012-06-07T04:25:14Z
dc.date.issued1999en_US
dc.identifier.citationRegulating Homeopathic Drugs: Pragmatic Solutions for the Food and Drug Administration (1999 Third Year Paper)en
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:8846788
dc.description.abstractDespite the growth of both the use of homeopathic drugs and the homeopathic drug industry, the Food and Drug Administration (FDA) has not altered its regulatory scheme for homeopathic drugs. As a result, homeopathic drugs are allowed on the market without any evidence that they are either safe or effective. The growing use of homeopathic drugs suggests that the FDA should reconsider its stance on homeopathic drugs so as to ensure consumer safety but yet preserve consumer choice.en
dc.language.isoen_USen
dash.licenseLAAen_US
dc.subjectFood and Drug Lawen
dc.subjectFDAen
dc.subjectregulationen
dc.subjecthomeopathicen
dc.subjecthomeopathyen
dc.titleRegulating Homeopathic Drugs: Pragmatic Solutions for the Food and Drug Administrationen
dc.typePaper (for course/seminar/workshop)en_US
dc.date.available2012-06-07T04:25:14Z
dash.authorsorderedfalse


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record